Medications for Managing Aggressive Behavior
For acute agitation, use benzodiazepines (lorazepam 2 mg IM) or antipsychotics (haloperidol 5 mg IM) depending on the suspected etiology, with benzodiazepines preferred for medical/intoxication causes and antipsychotics for psychiatric causes. 1
Acute Management of Agitation
First-Line Agents by Etiology
For medical causes or intoxication:
- Benzodiazepines are the preferred first-line agents 1
- Lorazepam 0.05-0.1 mg/kg IM/PO (adult dose: 2 mg) may be repeated every 30-60 minutes 1
- Onset: 15 minutes IM, 20-30 minutes PO; Duration: 6-8 hours 1
- Advantages: No extrapyramidal symptoms (EPS), effective for withdrawal syndromes 1
For psychiatric causes:
- Antipsychotics are preferred as first-line agents 1
- Haloperidol 5-10 mg IM for adolescents (0.5-1 mg for younger adolescents), may repeat every 2 hours 1
- Onset: 20-30 minutes IM; Duration: 4-8 hours 1
- Ziprasidone 20 mg IM is effective with fewer movement disorders compared to haloperidol 1
For unknown etiology:
- Give one dose of either benzodiazepine or antipsychotic; if ineffective, add the other medication class 1
Critical Cautions for Acute Management
- Antipsychotics are contraindicated in anticholinergic or sympathomimetic intoxication due to potential exacerbation of agitation 1
- Always offer oral medication before parenteral administration 1
- Avoid prone restraints that obstruct airways or restrict lung expansion 1
- Chemical restraint requires continuous monitoring by trained nursing personnel 1
Chronic Aggression Management by Underlying Condition
ADHD with Aggression
Stimulants are the first-line treatment, as they reduce both ADHD symptoms and antisocial behaviors. 2, 3
- Methylphenidate starting dose: 0.3-0.6 mg/kg/dose, 2-3 times daily 1
- Efficacy rate: 49% in children with ASD versus 15.5% on placebo 4
If aggression persists despite adequate stimulant treatment:
- Add divalproex sodium as adjunctive therapy (maximum 20-30 mg/kg/day divided BID-TID) 2
- Alternative: Alpha-2 agonists as adjunctive treatment 2
Conduct Disorder with Emotional Dysregulation
Divalproex sodium is the preferred adjunctive agent for aggressive outbursts. 2, 3
- Response rate: 53% for mania and mixed episodes in children/adolescents 2
- Lithium carbonate is an alternative for adolescents ≥12 years, particularly with family history of lithium response 2
- Requires more intensive monitoring but FDA-approved for this age group 2
For persistent aggression:
- Risperidone 0.5-2 mg/day has the strongest evidence when added to stimulants 2
- Monitor for metabolic syndrome, movement disorders, and prolactin elevation 2, 3
Autism Spectrum Disorder or Intellectual Disability with Severe Aggression
Risperidone (0.5-3.5 mg/day) is FDA-approved and first-line for irritability and aggression in ASD. 4, 3, 5
- Response rate: 69% versus 12% on placebo 3
- Starting dose: 0.25 mg/day if <20 kg, 0.5 mg/day if ≥20 kg 5
- Mean effective dose: 1.9 mg/day (0.06 mg/kg/day) 5
Aripiprazole (5-15 mg/day) is an alternative FDA-approved option. 4, 3
Combining medication with parent training is moderately more efficacious than medication alone. 4
Bipolar Disorder with Aggression
Mood stabilizers are first-line for reactive aggression. 2
- Divalproex sodium or lithium have demonstrated efficacy 2
- Risperidone adjunctive with lithium or valproate showed efficacy in open-label trials 2
- Monitor lithium levels (therapeutic range: 0.6-1.4 mEq/L) and ensure consistent dosing 4
Treatment Algorithm
Step 1: Identify and Treat Underlying Disorder
- Diagnose the primary psychiatric condition driving aggression 1, 6
- Rule out medical causes (epilepsy, endocrine disorders, organic brain disorders) 6
- Assess for triggers, warning signs, and prior response to treatment 1
Step 2: Implement Psychosocial Interventions First
- Anger management, problem-solving, and psychoeducational programs 1, 2
- Family-based therapy and intensive in-home therapies (multisystemic therapy) 2
- De-escalation strategies and behavioral interventions are essential 1, 4
Step 3: Initiate Pharmacotherapy Based on Diagnosis
- ADHD: Start stimulants 2, 3
- Conduct disorder: Add divalproex sodium if aggression persists 2, 3
- ASD/intellectual disability: Start risperidone or aripiprazole 4, 3
- Bipolar disorder: Use mood stabilizers (divalproex or lithium) 2
Step 4: Optimize and Augment
- Trial duration: Minimum 6-8 weeks at therapeutic doses/levels before declaring failure 2
- If inadequate response, add atypical antipsychotic (risperidone preferred) 2, 3
- Avoid polypharmacy—try one medication class thoroughly before switching 2
Step 5: Monitor and Adjust
- Regular assessment using standardized rating scales 4
- Monitor medication adherence and possible diversion 2
- For atypical antipsychotics: Monitor metabolic parameters, movement disorders, prolactin levels 2, 3
- For mood stabilizers: Monitor blood levels and hepatic/renal function 2, 4
Critical Pitfalls to Avoid
Do not use seclusion/restraint as punishment or for staff convenience. 1
Do not prescribe medication without identifying an underlying psychiatric disorder. 3
Avoid short-term dramatic interventions like "boot camps"—they are ineffective and potentially harmful. 2
Do not use quetiapine when evidence-based alternatives exist, as it lacks specific evidence for aggression. 3
Avoid long-term benzodiazepines due to unfavorable risk-benefit profiles. 4
Do not substitute medication for behavioral interventions—combination therapy is superior. 4, 3
For chemical restraint, consider cardiovascular effects and drug interactions carefully. 2
Proactive aggression is more challenging to treat than reactive aggression and has poorer outcomes. 2